CRB
Chad R. Baker Portfolio holdings
AUM
$538M
This Quarter Return
+12.61%
1 Year Return
+20.8%
3 Year Return
+87.18%
5 Year Return
+140.51%
10 Year Return
–
AUM
$538M
AUM Growth
+$538M
(+9.6%)
Cap. Flow
-$307K
Cap. Flow
% of AUM
-0.06%
Top 10 Holdings %
Top 10 Hldgs %
43.99%
Holding
50
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Cigna
CI
|
$194K |
| 2 |
Amphenol
APH
|
$113K |
Sector Composition
| 1 | Technology | 30.55% |
| 2 | Industrials | 21.7% |
| 3 | Healthcare | 15.98% |
| 4 | Consumer Discretionary | 12.32% |
| 5 | Communication Services | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Norfolk Southern
NSC
$62.4B
| $8.68M | 1.61% |
33,906
| – | – |
|
27
Procter & Gamble
PG
$370B
| $8.4M | 1.56% |
52,710
| – | – |
|
28
New York Times
NYT
$9.63B
| $8.02M | 1.49% |
143,325
| – | – |
|
29
Home Depot
HD
$404B
| $7.9M | 1.47% |
21,545
| – | – |
|
30
TJX Companies
TJX
$155B
| $7.7M | 1.43% |
62,340
| – | – |
|
31
Stryker
SYK
$149B
| $7.58M | 1.41% |
19,170
| – | – |
|
32
Lowe's Companies
LOW
$145B
| $6.23M | 1.16% |
28,100
| – | – |
|
33
RTX Corp
RTX
$212B
| $5.6M | 1.04% |
38,348
| – | – |
|
34
Salesforce
CRM
$242B
| $4.78M | 0.89% |
17,525
| – | – |
|
35
Colgate-Palmolive
CL
$68.2B
| $4.65M | 0.86% |
51,200
| – | – |
|
36
CRISPR Therapeutics
CRSP
$4.79B
| $4.53M | 0.84% |
93,205
| – | – |
|
37
Vertex Pharmaceuticals
VRTX
$103B
| $4.34M | 0.81% |
9,740
| – | – |
|
38
Alphabet (Google) Class C
GOOG
$2.56T
| $3.92M | 0.73% |
22,100
| – | – |
|
39
Zoetis
ZTS
$67.8B
| $3.87M | 0.72% |
24,818
| – | – |
|
40
Adobe
ADBE
$147B
| $3.48M | 0.65% |
9,000
| – | – |
|
41
CSX Corp
CSX
$60B
| $3.33M | 0.62% |
102,000
| – | – |
|
42
Airbnb
ABNB
$78.1B
| $3.17M | 0.59% |
23,955
| – | – |
|
43
McCormick & Company Non-Voting
MKC
$18.5B
| $2.61M | 0.48% |
34,370
| – | – |
|
44
Arm
ARM
$140B
| $1.97M | 0.37% |
12,155
| – | – |
|
45
Exxon Mobil
XOM
$489B
| $1.77M | 0.33% |
16,400
| – | – |
|
|
46
Cigna
CI
$80.3B
| $1.74M | 0.32% |
5,254
-587
| -10% | -$194K |
|
47
NVIDIA
NVDA
$4.16T
| $1.55M | 0.29% |
9,795
| – | – |
|
48
Merck
MRK
$214B
| $1.24M | 0.23% |
15,700
| – | – |
|
49
Becton Dickinson
BDX
$53.9B
| $934K | 0.17% |
5,420
| – | – |
|
50
Novo Nordisk
NVO
$251B
| $332K | 0.06% |
4,815
| – | – |
|